ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · CLRB

Atlas market file · Equity · United States

Cellectar Biosciences, Inc.CLRB

Last close
2.52
Change
-1.56%
96-bar range
2.2 – 4.7
As of
5 Aug 2026

Cellectar Biosciences, Inc. is a pharmaceutical preparations issuer listed as CLRB on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:CLRB

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

4.7754.11253.452.78752.12519 Mar28 May05 Aug

up candle   down candle

Latest close2.52
Day change-1.56%
Window high4.7
Window low2.2
96-bar change-20.75%
SnapshotDaily · 96 bars
As of2026-08-05 13:30 UTC

Weekly outlook: the last 104 weekly closes (-96.04% over the window).

68.5508unknown19 Aug05 Aug

Source rail: Yahoo Finance chart API (CLRB). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for CLRB. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

CLRB public profile

Company

Pharmaceutical preparations issuer. Cellectar Biosciences, Inc. is connected to current market context, cited company sources and its retained research file.

Market

Cellectar Biosciences, Inc. trades as CLRB on NASDAQ. Cellectar Biosciences, Inc. (CLRB) has a latest verified close of 2.52, down 1.56%, dated 5 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CLRB under USA Stocks and Science & Biotech Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Cellectar Biosciences, Inc. is a pharmaceutical preparations issuer listed as CLRB on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Ticker
CLRB
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

CLRB technical readout

Trend strength (ADX 14)
18.3
Average true range (ATR 14)
0.181
ATR as % of price
7.24%
Volatility compression (ATR14/ATR50)
0.77x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

CLRB evidence rails

Atlas uses the specific public rails available for CLRB: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on CLRB

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for CLRB Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep CLRB research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CLRB FAQ

What is Cellectar Biosciences, Inc. (CLRB)?Cellectar Biosciences, Inc. (CLRB) has a latest verified close of 2.52, down 1.56%, dated 5 Aug 2026. Use this page to check the price chart, company context,...

Cellectar Biosciences, Inc. (CLRB) has a latest verified close of 2.52, down 1.56%, dated 5 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for CLRB?Cellectar Biosciences, Inc. (CLRB) has a latest verified close of 2.52, down 1.56%, dated 5 Aug 2026. It brings the latest available chart, company context, cited...

Cellectar Biosciences, Inc. (CLRB) has a latest verified close of 2.52, down 1.56%, dated 5 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CLRB under USA Stocks and Science & Biotech Stocks for browsing.

How often is the CLRB page updated?The CLRB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The CLRB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for CLRB?The CLRB file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CLRB. SEC EDGAR provides the filing anchor for this issuer. The page separates...

The CLRB file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:CLRB. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on CLRB?Yes. The workstation can open a research path for CLRB from the public symbol record and then pull the available public sources for the fuller report.

Yes. The workstation can open a research path for CLRB from the public symbol record and then pull the available public sources for the fuller report.

Is this CLRB page investment advice?No. The CLRB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The CLRB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-07-28. Browse FreedomCore Atlas research notes →